Innovative drug concept strengthens again, ReJing Biotech rises more than 10% to hit a historic high.

In early trading, the concept of innovative medicine once again strengthened, with ReJun Biological rising more than 10% and its stock price reaching a historical high. Junshi Biosciences, Hongbo Pharmaceutical also rose more than 10%, and Chenxin Pharmaceutical, Kanghong Pharmaceutical, Hait Bio, Bio-Thera Solutions, and Jinkai Technology followed suit.